Table 2.
Frequency of NY-ESO-1 positive and NSE positive in SCLC patients
| Markers positive | SCLC patients (n = 57) | Controls (n = 47) | |
|---|---|---|---|
|
| |||
| LD-SCLC (n) | ED-SCLC (n) | BPD and NPD (n) | |
| NY-ESO-1ab only | 4 | 5 | 1 |
| NSE only | 5 | 14 | 3 |
| NY-ESO-1ab and NSE | 3 | 3 | 0 |
| None | 6 | 17 | 43 |
| Total | 18 | 39 | 47 |